Systems biomarkers as acute diagnostics and chronic monitoring tools for traumatic brain injury

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 8723, Issue , 2013, Pages

  Wang, Kevin K W ^a   Moghieb, Ahmed ^a,b   Yang, Zhihui ^a   Zhang, Zhiqun ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b University of Florida ^*  (United States)

Author keywords

Biomarkers; Cell injury; Detection technology; Diagnostic; Traumatic brain injury

Indexed keywords

BIOLOGICAL PROBLEMS; CELL INJURY; DETECTION TECHNOLOGY; DIAGNOSTIC; GENETIC POLYMORPHISMS; INFLAMMATORY CYTOKINES; MULTIPLE BIOMARKERS; TRAUMATIC BRAIN INJURIES;

BRAIN; ENVIRONMENTAL ENGINEERING; RNA; SECONDARY RECOVERY;

BIOMARKERS;

EID: 84881151397     PISSN: 0277786X     EISSN: 1996756X     Source Type: Conference Proceeding    
DOI: 10.1117/12.2020030     Document Type: Conference Paper

References (145)

1. CDC, "Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006"1-74 (2010).
2. Hoffman, S.W., and Harrison, C., "The interaction between psychological health and traumatic brain injury: a neuroscience perspective," Clin Neuropsychol 23(8), 1400-1415 (2009).
3. Jager, T.E., Weiss, H.B., Coben, J.H., and Pepe, P.E., "Traumatic brain injuries evaluated in U.S. emergency departments, 1992-1994," Acad Emerg Med 7(2), 134-140 (2000).
4. Elovic, E., Doppalapudi, H.S., and Miller, M., "Endocrine abnormalities and fatigue after traumatic brain injury," J Head Trauma Rehab. 21(5), 426-427 (2006).
5. Englander, J., Bushnik, T., Oggins, J., and Katznelson, L., "Fatigue after traumatic brain injury: Association with neuroendocrine, sleep, depression and other factors," Brain injury : [BI] 24(12), 1379-1388 (2010).
6. Rigg, J.L., and Mooney, S.R., "Concussions and the military: issues specific to service members.," PM & R : the journal of injury, function, and rehabilitation 3(10 Suppl 2), S380-6 (2011).
7. Hoge, C.W., Castro, C.A., Messer, S.C., McGurk, D., Cotting, D.I., and Koffman, R.L., "Combat duty in Iraq and Afghanistan, mental health problems and barriers to care," US Army Med Dep J7-17 (2008).
8. Ponsford, J., Willmott, C., Rothwell, A., Cameron, P., Ayton, G., Nelms, R., Curran, C., and Ng, K., "Impact of early intervention on outcome after mild traumatic brain injury in children.," PEDIATRICS 108(6), 1297-1303 (2001).
9. Ponsford, J., Willmott, C., Rothwell, A., Cameron, P., Kelly, A.-M., Nelms, R., and Curran, C., "Impact of early intervention on outcome following mild head injury in adults.," Journal of Neurology, Neurosurgery & Psychiatry 73(3), 330-332 (2002).
10. Wade, D.T., King, N.S., Wenden, F.J., Crawford, S., and Caldwell, F.E., "Routine follow up after head injury: a second randomised controlled trial.," Journal of Neurology, Neurosurgery & Psychiatry 65(2), 177-183 (1998).
11. Carroll, L.J., Cassidy, J.D., Peloso, P.M., Borg, J., Holst, von, H., Holm, L., Paniak, C., Pépin, M., WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury, "Prognosis for mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury.," Journal of Rehabilitation Medicine(43 Suppl), 84-105 (2004).
12. Topolovec-Vranic, J., Pollmann-Mudryj, M.-A., Ouchterlony, D., Klein, D., Spence, J., Romaschin, A., Rhind, S., Tien, H.C., and Baker, A.J., "The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.," The Journal of trauma 71(5 Suppl 1), S478-86 (2011).
13. Agoston, D.V., Gyorgy, A., Eidelman, O., and Pollard, H.B., "Proteomic Biomarkers for Blast Neurotrauma: Targeting Cerebral Edema, Inflammation, and Neuronal Death Cascades," Journal of neurotrauma 26(6), 901-911 (2009).
14. Sivanandam, T.M., and Thakur, M.K., "Traumatic brain injury: a risk factor for Alzheimer's disease.," Neuroscience and biobehavioral reviews 36(5), 1376-1381 (2012).
15. Dams-O'Connor, K., Gibbons, L.E., Bowen, J.D., McCurry, S.M., Larson, E.B., and Crane, P.K., "Risk for late-life re-injury, dementia and death among individuals with traumatic brain injury: a populationbased study.," J Neurol Neurosurg Psychiatry 84(2), 177-182 (2013).
16. Stern, R.A.R., Riley, D.O.D., Daneshvar, D.H.D., Nowinski, C.J.C., Cantu, R.C.R., and McKee, A.C.A., "Long-term Consequences of Repetitive Brain Trauma: Chronic Traumatic Encephalopathy," PMRJ 3(10 Suppl 2), 0-0 (2011).
17. Baugh, C.M., Stamm, J.M., Riley, D.O., Gavett, B.E., Shenton, M.E., Lin, A., Nowinski, C.J., Cantu, R.C., McKee, A.C., et al., "Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma," Brain Imaging Behav 6(2), 244-254 (2012).
18. Omalu, B.I., Hamilton, R.L., Kamboh, M.I., DeKosky, S.T., and Bailes, J., "Chronic traumatic encephalopathy (CTE) in a National Football League Player: Case report and emerging medicolegal practice questions," Journal of Forensic Nursing 6(1), 40-46 (2010).
19. Saatman, K.E., Duhaime, A.-C., Bullock, R., Maas, A.I.R., Valadka, A., and Manley, G.T., "Classification of Traumatic Brain Injury for Targeted Therapies," Journal of neurotrauma 25(7), 719-738 (2008).
20. Denslow, N., Michel, M.E., Temple, M.D., Hsu, C.Y., Saatman, K., and Hayes, R.L., "Application of proteomics technology to the field of neurotrauma," Journal of neurotrauma 20(5), 401-407 (2003).
21. Kobeissy, F.H., Ottens, A.K., Zhang, Z., Liu, M.C., Denslow, N.D., Dave, J.R., Tortella, F.C., Hayes, R.L., Wang, K.K., et al., "Novel differential neuroproteomics analysis of traumatic brain injury in rats," Molecular \& Cellular Proteomics 5(10), 1887-1898 (2006).
22. Kobeissy, F.H., Guingab-Cagmat, J.D., Razafsha, M., O'Steen, L., Zhang, Z., Hayes, R.L., Chiu, W.-T., and Wang, K.K.W., "Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research.," PM & R : the journal of injury, function, and rehabilitation 3(6, Supplement), S139-S147 (2011).
23. Papa, L., Robinson, G., Oli, M., Pineda, J., Demery, J., Brophy, G., Robicsek, S.A., Gabrielli, A., Robertson, C.S., et al., "Use of biomarkers for diagnosis and management of traumatic brain injury patients" (2008).
24. Manley, G.T., Diaz-Arrastia, R., Brophy, M., Engel, D., Goodman, C., Gwinn, K., Veenstra, T.D., Ling, G., Ottens, A.K., et al., "Common Data Elements for Traumatic Brain Injury: Recommendations From the Biospecimens and Biomarkers Working Group," YAPMR 91(11), 1667-1672 (2010).
25. Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., and Hagenstrom, H., "Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results," Clin Chem 45(1), 138-141 (1999).
26. Ross, S.A., Cunningham, R.T., Johnston, C.F., and Rowlands, B.J., "Neuron-specific enolase as an aid to outcome prediction in head injury," British Journal of Neurosurgery 10(5), 471-476 (1996).
27. Yamazaki, Y., Yada, K., Morii, S., Kitahara, T., and Ohwada, T., "Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury," Surg Neurol 43(3), 267-70- discussion 270-1 (1995).
28. Raabe, A., and Seifert, V., "Fatal secondary increase in serum S-100B protein after severe head injury. Report of three cases," Journal of neurosurgery 91(5), 875-877 (1999).
29. Romner, B., Ingebrigtsen, T., Kongstad, P., and Borgesen, S.E., "Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings," Journal of neurotrauma 17(8), 641-647 (2000).
30. Johnsson, P., Blomquist, S., Luhrs, C., Malmkvist, G., Alling, C., Solem, J.O., and Stahl, E., "Neuronspecific enolase increases in plasma during and immediately after extracorporeal circulation," The Annals of thoracic surgery 69(3), 750-754 (2000).
31. Pelinka, L.E., Szalay, L., Jafarmadar, M., Schmidhammer, R., Redl, H., and Bahrami, S., "Circulating S100B is increased after bilateral femur fracture without brain injury in the rat," Br J Anaesth 91(4), 595-597 (2003).
32. Pelinka, L.E., Hertz, H., Mauritz, W., Harada, N., Jafarmadar, M., Albrecht, M., Redl, H., and Bahrami, S., "Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings.," Shock 24(2), 119-123 (2005).
33. Pelinka, L.E., Kroepfl, A., Schmidhammer, R., Krenn, M., Buchinger, W., Redl, H., and Raabe, A., "Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma," The Journal of trauma 57(5), 1006-1012 (2004).
34. Berger, R.P., Kochanek, P.M., and Pierce, M.C., "Biochemical markers of brain injury: could they be used as diagnostic adjuncts in cases of inflicted traumatic brain injury?," Child Abuse & Neglect 28(7), 739-754 (2004).
35. Berger, R.P., Beers, S.R., Richichi, R., Wiesman, D., and Adelson, P.D., "Serum Biomarker Concentrations and Outcome after Pediatric Traumatic Brain Injury," Journal of neurotrauma 24(12), 1793-1801 (2007).
36. Fountoulakis, M., "Application of proteomics technologies in the investigation of the brain," Mass spectrometry reviews 23(4), 231-258 (2004).
37. Lubec, G., Krapfenbauer, K., and Fountoulakis, M., "Proteomics in brain research: potentials and limitations," Progress in Neurobiology 69(3), 193-211 (2003).
38. Haskins, W.E., Kobeissy, F.H., Wolper, R.A., Ottens, A.K., Kitlen, J.W., McClung, S.H., O'Steen, B.E., Chow, M.M., Pineda, J.A., et al., "Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry.," Journal of neurotrauma 22(6), 629-644 (2005).
39. Katano, T., Mabuchi, T., Okuda-Ashitaka, E., Inagaki, N., Kinumi, T., and Ito, S., "Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia.," PROTEOMICS 6(22), 6085-6094 (2006).
40. Crack, P.J.P., Gould, J.J., Bye, N.N., Ross, S.S., Ali, U.U., Habgood, M.D.M., Morganti-Kossman, C.C., Saunders, N.R.N., and Hertzog, P.J.P., "The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline.," Journal of Neural Transmission 116(1), 1-12 (2009).
41. Lei, P., Li, Y., Chen, X., Yang, S., and Zhang, J., "Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury.," Brain Res 1284, 191-201 (2009).
42. Balakathiresan, N., Bhomia, M., Chandran, R., Chavko, M., McCarron, R.M., and Maheshwari, R.K., "MicroRNA Let-7i Is a Promising Serum Biomarker for Blast-Induced Traumatic Brain Injury," Journal of neurotrauma 29(7), 1379-1387 (2012).
43. Redell, J.B., Liu, Y., and Dash, P.K., "Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes," Journal of neuroscience research 87(6), 1435-1448 (2009).
44. Siman, R., McIntosh, T.K., Soltesz, K.M., Chen, Z., Neumar, R.W., Roberts, V.L., Siman, R., McIntosh, T.K., Soltesz, K.M., et al., "Proteins released from degenerating neurons are surrogate markers for acute brain damage," Neurobiology of Disease 16(2), 311-320 (2004).
45. Siman, R., Baudry, M., and Lynch, G., "Brain fodrin: substrate for calpain I, an endogenous calciumactivated protease," Proceedings of the National Academy of Sciences of the United States of America 81(11), 3572-3576 (1984).
46. Pike, B.R., Flint, J., Dave, J.R., Lu, X.-C.M., Wang, K.K.K., Tortella, F.C., and Hayes, R.L., "Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.," Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 24(1), 98-106 (2004).
47. Pike, B.R., Flint, J., Dutta, S., Johnson, E., Wang, K.K., Hayes, R.L., Pike, B.R., Flint, J., Dutta, S., et al., "Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats," Journal of neurochemistry 78(6), 1297-1306 (2001).
48. Mondello, S., Robicsek, S.A., Gabrielli, A., Brophy, G.M., Papa, L., Tepas, J., Robertson, C., Buki, A., Scharf, D., et al., "alphaII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients," Journal of neurotrauma 27(7), 1203-1213 (2010).
49. Zemlan, F.P., Jauch, E.C., Mulchahey, J.J., Gabbita, S.P., Rosenberg, W.S., Speciale, S.G., and Zuccarello, M., "C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome," Brain research 947(1), 131-139 (2002).
50. Shaw, G.J., Jauch, E.C., and Zemlan, F.P., "Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury," Annals of emergency medicine 39(3), 254-257 (2002).
51. Siman, R., Zhang, C., Roberts, V.L., Pitts-Kiefer, A., and Neumar, R.W., "Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat," Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 25(11), 1433-1444 (2005).
52. Dambinova, S.A., Bettermann, K., Glynn, T., Tews, M., Olson, D., Weissman, J.D., and Sowell, R.L., "Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke.," PloS one 7(7), e42362 (2012).
53. Petzold, A., Rejdak, K., Belli, A., Sen, J., Keir, G., Kitchen, N., Smith, M., and Thompson, E.J., "Axonal pathology in subarachnoid and intracerebral hemorrhage," Journal of neurotrauma 22(3), 407-414 (2005).
54. Petzold, A., and Shaw, G., "Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain," J Immunol Methods 319(1-2), 34-40 (2007).
55. Anderson, K.J., Scheff, S.W., Miller, K.M., Roberts, K.N., Gilmer, L.K., Yang, C., and Shaw, G., "The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury," Journal of neurotrauma 25(9), 1079-1085 (2008).
56. Pelsers, M.M.A.L., and Glatz, J.F.C., "Detection of brain injury by fatty acid-binding proteins," Clinical Chemical Laboratory Medicine 43(8).
57. Pelsers, M.M.A.L., Hermens, W.T., and Glatz, J.F.C., "Fatty acid-binding proteins as plasma markers of tissue injury," Clinica Chimica Acta 352(1-2), 15-35 (2005).
58. Liu, M.C., Akle, V., Zheng, W., Dave, J.R., Tortella, F.C., Hayes, R.L., Wang, K.K., Liu, M.C., Akle, V., et al., "Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis.," The Biochemical journal 394(Pt 3), 715-725 (2006).
59. Yao, C., Williams, A.J., Ottens, A.K., May Lu, X.-C., Chen, R., Wang, K.K., Hayes, R.L., Tortella, F.C., Dave, J.R., et al., "Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats.," Brain injury : [BI] 22(10), 723-732 (2008).
60. Yao, C., Williams, A.J., Ottens, A.K., Lu, X.-C.M., Liu, M.C., Hayes, R.L., Wang, K.K., Tortella, F.C., and Dave, J.R., "P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury.," Journal of neurotrauma 26(8), 1295-1305 (2009).
61. Ottens, A.K., Bustamante, L., Golden, E.C., Yao, C., Hayes, R.L., Wang, K.K.W., Tortella, F.C., and Dave, J.R., "Neuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.," Journal of neurotrauma 27(10), 1837-1852 (2010).
62. Kobeissy, F.H., Sadasivan, S., Oli, M.W., Robinson, G., Larner, S.F., Zhang, Z., Hayes, R.L., and Wang, K.K.W., "Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation.," Proteomics. Clinical applications 2(10-11), 1467-1483 (2008).
63. Liu, M.C., Akinyi, L., Scharf, D., Mo, J., Larner, S.F., Muller, U., Oli, M.W., Zheng, W., Kobeissy, F., et al., "Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats.," The European journal of neuroscience 31(4), 722-732 (2010).
64. Svetlov, S.I., Prima, V., Kirk, D.R., Gutierrez, H., Curley, K.C., Hayes, R.L., and Wang, K.K.W., "Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure.," The Journal of trauma 69(4), 795-804 (2010).
65. Papa, L., Akinyi, L., Liu, M.C., Pineda, J.A., Tepas, J.J., Oli, M.W., Zheng, W., Robinson, G., Robicsek, S.A., et al., "Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.," Critical care medicine 38(1), 138-144 (2010).
66. Brophy, G.M., Mondello, S., Papa, L., Robicsek, S.A., Gabrielli, A., Tepas, J., Buki, A., Robertson, C., Tortella, F.C., et al., "Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids.," Journal of neurotrauma 28(6), 861-870 (2011).
67. Siman, R., Roberts, V.L., McNeil, E., Dang, A., Bavaria, J.E., Ramchandren, S., and McGarvey, M., "Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest," Brain research 1213, 1-11 (2008).
68. Siman, R., Toraskar, N., Dang, A., McNeil, E., McGarvey, M., Plaum, J., Maloney, E., and Grady, M.S., "A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans," Journal of neurotrauma 26(11), 1867-1877 (2009).
69. Lewis, S.B., Wolper, R., Chi, Y.-Y., Miralia, L., Wang, Y., Yang, C., and Shaw, G., "Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage.," Journal of neuroscience research 88(7), 1475-1484 (2010).
70. Zhang, Z., Mondello, S., Kobeissy, F., Rubenstein, R., Streeter, J., Hayes, R.L., and Wang, K.K.W., "Protein biomarkers for traumatic and ischemic brain injury: from bench to bedside," Translational Stroke Research 3, 1-32 (2011).
71. Svetlov, S.I., Prima, V., Glushakova, O., Svetlov, A., Kirk, D.R., Gutierrez, H., Serebruany, V.L., Curley, K.C., Wang, K.K.W., et al., "Neuro-glial and systemic mechanisms of pathological responses in rat models of primary blast overpressure compared to 'composite' blast.," Frontiers in neurology 3, 15 (2012).
72. Papa, L., Lewis, L.M., Falk, J.L., Zhang, Z., Silvestri, S., Giordano, P., Brophy, G.M., Demery, J.A., Dixit, N.K., et al., "Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.," Annals of emergency medicine 59(6), 471-483 (2012).
73. Mondello, S., Gabrielli, A., Catani, S., D'Ippolito, M., Jeromin, A., Ciaramella, A., Bossù, P., Schmid, K., Tortella, F., et al., "Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury.," Brain injury : [BI] (0), 1-7 (2012).
74. Wagner, A.K., and Zitelli, K.T., "A Rehabilomics focused perspective on molecular mechanisms underlying neurological injury, complications, and recovery after severe TBI," Pathophysiology (2012).
75. Varma, S., Janesko, K.L., Wisniewski, S.R., Bayir, H., Adelson, P.D., Thomas, N.J., and Kochanek, P.M., "F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children," Journal of neurotrauma 20(8), 781-786 (2003).
76. Wagner, A.K., Bayir, H., Ren, D., Puccio, A., Zafonte, R.D., and Kochanek, P.M., "Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia.," Journal of neurotrauma 21(2), 125-136 (2004).
77. Begaz, T.T., Kyriacou, D.N.D., Segal, J.J., and Bazarian, J.J.J., "Serum biochemical markers for postconcussion syndrome in patients with mild traumatic brain injury.," Journal of neurotrauma 23(8), 1201-1210 (2006).
78. Kang, J.-H., and Lin, H.-C., "Increased risk of multiple sclerosis after traumatic brain injury: a nationwide population-based study.," Journal of neurotrauma 29(1), 90-95 (2012).
79. Lee, P.-C., Bordelon, Y., Bronstein, J., and Ritz, B., "Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease.," Neurology 79(20), 2061-2066 (2012).
80. Smith, D.H., Chen, X.H., Nonaka, M., Trojanowski, J.Q., Lee, V.M., Saatman, K.E., Leoni, M.J., Xu, B.N., Wolf, J.A., et al., "Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig," Journal of neuropathology and experimental neurology 58(9), 982-992 (1999).
81. Duan, Y., Dong, S., Gu, F., Hu, Y., and Zhao, Z., "Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration.," Translational neurodegeneration 1(1), 24 (2012).
82. McKee, A.C., Cantu, R.C., Nowinski, C.J., Hedley-Whyte, E.T., Gavett, B.E., Budson, A.E., Santini, V.E., Lee, H.S., Kubilus, C.A., et al., "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury," Journal of neuropathology and experimental neurology 68(7), 709-735 (2009).
83. Goldstein, L.E., Fisher, A.M., Tagge, C.A., Zhang, X.L., Velisek, L., Sullivan, J.A., Upreti, C., Kracht, J.M., Ericsson, M., et al., "Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model," Science Translational Medicine 4(134), 134ra60-134ra60 (2012).
84. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A., et al., "Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis," J Neurosci 18(18), 7061-7074 (1998).
85. Park, S.Y., Tournell, C., Sinjoanu, R.C., and Ferreira, A., "Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons," NSC 144(1), 119-127 (2007).
86. Liu, M.C., Kobeissy, F., Zheng, W., Zhang, Z., Hayes, R.L., and Wang, K.K.W., "Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions.," ASN neuro 3(1), e00051 (2011).
87. Haas, B.R., Stewart, T.H., and Zhang, J., "Premotor biomarkers for Parkinson's disease - a promising direction of research.," Translational neurodegeneration 1(1), 11 (2012).
88. Mollenhauer, B., and Zhang, J., "Biochemical premotor biomarkers for Parkinson's disease.," Movement disorders : official journal of the Movement Disorder Society 27(5), 644-650 (2012).
89. Ramlackhansingh, A.F., Brooks, D.J., Greenwood, R.J., Bose, S.K., Turkheimer, F.E., Kinnunen, K.M., Gentleman, S., Heckemann, R.A., Gunanayagam, K., et al., "Inflammation after trauma: Microglial activation and traumatic brain injury," Annals of Neurology 70(3), 374-383 (2011).
90. Smith, C., Gentleman, S.M., Leclercq, P.D., Murray, L.S., Griffin, W.S.T., Graham, D.I., and Nicoll, J.A.R., "The neuroinflammatory response in humans after traumatic brain injury.," Neuropathology and Applied Neurobiology [Epub ahead of print] (2012).
91. Jacobowitz, D.M., Cole, J.T., McDaniel, D.P., Pollard, H.B., and Watson, W.D., "Microglia activation along the corticospinal tract following traumatic brain injury in the rat: a neuroanatomical study.," Brain Res 1465, 80-89 (2012).
92. Johnson, V.E., Stewart, J.E., Begbie, F.D., Trojanowski, J.Q., Smith, D.H., and Stewart, W., "Inflammation and white matter degeneration persist for years after a single traumatic brain injury.," Brain 136(Pt 1), 28-42 (2013).
93. Kumar, A., and Loane, D.J., "Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention," BRAIN, BEHAVIOUR, AND IMMUNITY1-11 (2012).
94. Ziebell, J.M., and Morganti-Kossmann, M.C., "Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury," NURT 7(1), 22-30 (2010).
95. Maier, B., Laurer, H.-L., Rose, S., Buurman, W.A., and Marzi, I., "Physiological levels of pro- and antiinflammatory mediators in cerebrospinal fluid and plasma: a normative study.," Journal of neurotrauma 22(7), 822-835 (2005).
96. Chiaretti, A., Genovese, O., Aloe, L., Antonelli, A., Piastra, M., Polidori, G., and Rocco, C., "Interleukin 1 and interleukin 6 relationship with paediatric head trauma severity and outcome," Child's Nervous System 21(3), 185-193 (2004).
97. Folkersma, H., Brevé, J.J.P., Tilders, F.J.H., Cherian, L., Robertson, C.S., and Vandertop, W.P., "Cerebral microdialysis of interleukin (IL)-1beta and IL-6: extraction efficiency and production in the acute phase after severe traumatic brain injury in rats.," Acta Neurochirurgica 150(12), 1277-1284 (2008).
98. Bonneh-Barkay, D., Zagadailov, P., Zou, H., Niyonkuru, C., Figley, M., Starkey, A., Wang, G., Bissel, S.J., Wiley, C.A., et al., "YKL-40 expression in traumatic brain injury: an initial analysis.," Journal of neurotrauma 27(7), 1215-1223 (2010).
99. Thomas Woodcock, M.C.M.-K., "The Role of Markers of Inflammation in Traumatic Brain Injury," Frontiers in neurology 4, 18 (2013).
100. Abulafia, D.P., de Rivero Vaccari, J.P., Lozano, J.D., Lotocki, G., Keane, R.W., and Dietrich, W.D., "Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice," Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 29(3), 534-544 (2008).
101. de Rivero Vaccari, J.P., Lotocki, G., Marcillo, A.E., Dietrich, W.D., and Keane, R.W., "A molecular platform in neurons regulates inflammation after spinal cord injury.," Journal of Neuroscience 28(13), 3404-3414 (2008).
102. de Rivero Vaccari, J.P., Lotocki, G., Alonso, O.F., Bramlett, H.M., Dietrich, W.D., and Keane, R.W., "Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.," Journal of Cerebral Blood Flow & Metabolism 29(7), 1251-1261 (2009).
103. Adamczak, S., Dale, G., de Rivero Vaccari, J.P., Bullock, M.R., Dietrich, W.D., and Keane, R.W., "Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome," Journal of neurosurgery 117(6), 1119-1125 (2012).
104. Bavisetty, S., Bavisetty, S., McArthur, D.L., Dusick, J.R., Wang, C., Cohan, P., Boscardin, W.J., Swerdloff, R., Levin, H., et al., "Chronic Hypopituitarism After Traumatic Brain Injury: Risk Assessment and Relationship to Outcome," Neurosurgery 62(5), 1080 (2008).
105. Wilkinson, C.W., Pagulayan, K.F., Petrie, E.C., Mayer, C.L., Colasurdo, E.A., Shofer, J.B., Hart, K.L., Hoff, D., Tarabochia, M.A., et al., "High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury.," Frontiers in neurology 3, 11 (2012).
106. Wagner, J., Dusick, J.R., McArthur, D.L., Cohan, P., Wang, C., Swerdloff, R., Boscardin, W.J., and Kelly, D.F., "Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury.," Journal of neurotrauma 27(6), 1007-1019 (2010).
107. Wagner, A.K., Brett, C.A., McCullough, E.H., Niyonkuru, C., Loucks, T.L., Dixon, C.E., Ricker, J., Arenth, P., and Berga, S.L., "Persistent hypogonadism influences estradiol synthesis, cognition and outcome in males after severe TBI," Brain injury : [BI] 26(10), 1226-1242 (2012).
108. Hohl, A., Mazzuco, T.L., Coral, M.H.C., Schwarzbold, M., and Walz, R., "Hypogonadism after traumatic brain injury," Arquivos Brasileiros de Endocrinologia & Metabologia 53(8), 908-914 (2009).
109. Kozlowski Moreau, O., Yollin, E., Merlen, E., Daveluy, W., and Rousseaux, M., "Lasting pituitary hormone deficiency after traumatic brain injury.," Journal of neurotrauma 29(1), 81-89 (2012).
110. Guerrero, A.F., and Alfonso, A., "Traumatic brain injury-related hypopituitarism: a review and recommendations for screening combat veterans.," Mil Med 175(8), 574-580 (2010).
111. Wilkinson, C.W., Pagulayan, K.F., Petrie, E.C., Mayer, C.L., Colasurdo, E.A., Shofer, J.B., Hart, K.L., Hoff, D., Tarabochia, M.A., et al., "High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury.," Frontiers in neurology 3, 11 (2012).
112. Dubourg, J.J., and Messerer, M.M., "Sports-related chronic repetitive head trauma as a cause of pituitary dysfunction.," Neurosurg Focus 31(5), E2-E2 (2011).
113. Tanriverdi, F., De Bellis, A., Bizzarro, A., Sinisi, A.A., Bellastella, G., Pane, E., Bellastella, A., Unluhizarci, K., Selcuklu, A., et al., "Antipituitary antibodies after traumatic brain injury: is head traumainduced pituitary dysfunction associated with autoimmunity?," European Journal of Endocrinology 159(1), 7-13 (2008).
114. Tanriverdi, F.F., Unluhizarci, K.K., and Kelestrimur, F.F., "Persistent neuroinflammation may be involved in the pathogenesis of traumatic brain injury (TBI)-induced hypopituitarism: potential genetic and autoimmune factors.," Audio, Transactions of the IRE Professional Group on 27(2), 301-302 (2010).
115. De Bellis, A., Kelestimur, F., Agostino Sinisi, A., Ruocco, G., Tirelli, G., Battaglia, M., Bellastella, G., Conzo, G., Tanriverdi, F., et al., "Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome," European Journal of Endocrinology 158(2), 147-152 (2008).
116. Dambinova, S.A.S., Khounteev, G.A.G., Izykenova, G.A.G., Zavolokov, I.G.I., Ilyukhina, A.Y.A., and Skoromets, A.A.A., "Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke.," Clinical Chemistry 49(10), 1752-1762 (2003).
117. Colasanti, T.T., Barbati, C.C., Rosano, G.G., Malorni, W.W., and Ortona, E.E., "Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression," Autoimmunity Reviews 9(12), 5-5 (2010).
118. D'Andrea, M.R., "Add Alzheimer's disease to the list of autoimmune diseases," Medical Hypotheses 64(3), 6-6 (2005).
119. Ankeny, D.P., Lucin, K.M., Sanders, V.M., McGaughy, V.M., and Popovich, P.G., "Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis.," Journal of neurochemistry 99(4), 1073-1087 (2006).
120. Popovich, P.G.P., Stokes, B.T.B., and Whitacre, C.C.C., "Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system.," J Neurosci Res 45(4), 349-363 (1996).
121. Lancaster, E., and Dalmau, J., "Neuronal autoantigens-pathogenesis, associated disorders and antibody testing," Nature Reviews Neurology 8(7), 380-390 (2012).
122. Ponomarenko, N.A., Durova, O.M., Vorobiev, I.I., Belogurov, A.A., Telegin, G.B., Suchkov, S.V., Misikov, V.K., Morse, H.C., III, and Gabibov, A.G., "Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale," Immunology Letters 103(1), 45-50 (2006).
123. Hedegaard, C.J., Chen, N., Sellebjerg, F., Sørensen, P.S., Leslie, R.G.Q., Bendtzen, K., and Nielsen, C.H., "Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP," Immunology 128(1pt2), e451-e461 (2009).
124. Cox, A.L., Coles, A.J., Nortje, J., Bradley, P.G., Chatfield, D.A., Thompson, S.J., and Menon, D.K., "An investigation of auto-reactivity after head injury," Journal of Neuroimmunology 174(1-2), 180-186 (2006).
125. Sorokina, E.G.E., Semenova, Z.B.Z., Granstrem, O.K.O., Karaseva, O.V.O., Meshcheriakov, S.V.S., Reutov, V.P.V., Sushkevich, G.N.G., Pinelis, V.G.V., and Roshal, L.M.L., "[S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children] .," Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoi promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe obshchestvo nevrologov [i] Vserossiiskoe obshchestvo psikhiatrov 110(8), 30-35 (2010).
126. Goryunova, A.V.A., Bazarnaya, N.A.N., Sorokina, E.G.E., Semenova, N.Y.N., Globa, O.V.O., Semenova, Z.B.Z., Pinelis, V.G.V., Roshal, L.M.L., and Maslova, O.I.O., "Glutamate receptor autoantibody concentrations in children with chronic post-traumatic headache.," Neuroscience and Behavioral Physiology 37(8), 761-764 (2007).
127. Tanriverdi, F., De Bellis, A., Battaglia, M., Bellastella, G., Bizzarro, A., Sinisi, A.A., Bellastella, A., Unluhizarci, K., Selcuklu, A., et al., "Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity?," European Journal of Endocrinology 162(5), 861-867 (2010).
128. Daadi, M.M., "Novel paths towards neural cellular products for neurological disorders.," Regenerative medicine 6(6 Suppl), 25-30 (2011).
129. Mueller, B.K., Mueller, R., and Schoemaker, H., "Stimulating neuroregeneration as a therapeutic drug approach for traumatic brain injury," British Journal of Pharmacology 157(5), 675-685 (2009).
130. Richardson, R.M., Singh, A., Sun, D., Fillmore, H.L., Dietrich, D.W., and Bullock, M.R., "Stem cell biology in traumatic brain injury: effects of injury and strategies for repair.," Journal of neurosurgery 112(5), 1125-1138 (2010).
131. Chirumamilla, S., Sun, D., and Bullock, M.R., "Traumatic Brain Injury Induced Cell Proliferation in the Adult Mammalian Central Nervous
132. Chiaretti, A., Antonelli, A., Riccardi, R., Genovese, O., Pezzotti, P., Di Rocco, C., Tortorolo, L., and Piedimonte, G., "Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children," European Journal of Paediatric Neurology 12(3), 10-10 (2008).
133. Chiaretti, A., Barone, G., Riccardi, R., Antonelli, A., Pezzotti, P., Genovese, O., Tortorolo, L., and Conti, G., "NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.," Neurology 72(7), 609-616 (2009).
134. Johanson, C., Stopa, E., Baird, A., and Sharma, H., "Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus," Journal of Neural Transmission 118(1), 115-133 (2010).
135. Joyce, N., Annett, G., Wirthlin, L., Olson, S., Bauer, G., and Nolta, J.A., "Mesenchymal stem cells for the treatment of neurodegenerative disease," Regenerative medicine 5(6), 933-946 (2010).
136. Feng, Z., and Gao, F., "Stem cell challenges in the treatment of neurodegenerative disease.," CNS Neuroscience & Therapeutics 18(2), 142-148 (2012).
137. Temple, S., "The development of neural stem cells.," Nature 414(6859), 112-117 (2001).
138. Jain, K.K., [The Handbook of Biomarkers], Springer, New York (2010).
139. Zakharov, V.V., Bogdanova, M.N., and Mosevitsky, M.I., "Specific Proteolysis of Neuronal Protein GAP43 by Calpain: Characterization, Regulation, and Physiological Role," Biochemistry (Moscow) 70(8), 897-907 (2005).
140. Wang, L.H., and Strittmatter, S.M., "A family of rat CRMP genes is differentially expressed in the nervous system.," The Journal of Neuroscience 16(19), 6197-6207 (1996).
141. Touma, E., Kato, S., Fukui, K., and Koike, T., "Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice," European Journal of Neuroscience 26(12), 3368-3381 (2007).
142. Zhang, Z., Ottens, A.K., Sadasivan, S., Kobeissy, F.H., Fang, T., Hayes, R.L., and Wang, K.K.W., "Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury.," Journal of neurotrauma 24(3), 460-472 (2007).
143. Zhang, Z., Larner, S.F., Kobeissy, F., Hayes, R.L., and Wang, K.K.W., "Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.," Methods in molecular biology (Clifton, N.J.) 662, 317-329 (2010).
144. Lee, E.K., "Optimization-based predictive models in medicine and biology," Optimization in Medicine 12, 127-151 (2008).
145. Ju, L.G., and Lee, E.K., [Optimization in Medicine And Biology], L. G. J and E. K. Lee, Eds., Auerbach Publications, Taylor & Francis Group, Boca Raton, FL (2008).